Effect of Gonadotropin-Releasing Hormone Agonist Treatment in Boys with Central Precocious Puberty: Final Height Results

Publisher： Karger

E-ISSN： 1663-2826|58|1|1-7

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.58, Iss.1, 2002-08, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gonadotropin Releasing Hormone Agonist Treatment for Central Precocious Puberty

By  

Hormone Research in Paediatrics, Vol. 51, Iss. 3, 2004-11 ,pp. : 64-69

Karger

Access to resources Recommend Favorite

Central Precocious Puberty: A Single Blood Sample after Gonadotropin-Releasing Hormone Agonist Administration in Monitoring Treatment

By  

Hormone Research in Paediatrics, Vol. 50, Iss. 4, 1998-12 ,pp. : 205-211

Karger

Access to resources Recommend Favorite

Occurrence of Slipped Capital Femoral Epiphysis in Children Undergoing Gonadotropin-Releasing Hormone Agonist Therapy for the Treatment of Central Precocious Puberty

By  

Hormone Research in Paediatrics, Vol. 80, Iss. 1, 2013-07 ,pp. : 64-68

Karger

Access to resources Recommend Favorite

Body Mass Index and Body Composition in Adolescents Treated with Gonadotropin-Releasing Hormone Analogue Triptorelin Depot for Central Precocious Puberty: Data at Near Final Height

By  

Neuroendocrinology, Vol. 89, Iss. 4, 2009-01 ,pp. : 441-447

Karger

Access to resources Recommend Favorite

Subcutaneous Gonadotropin-Releasing Hormone Agonist (Triptorelin) Test for Diagnosing Precocious Puberty

By  

Hormone Research in Paediatrics, Vol. 72, Iss. 2, 2009-08 ,pp. : 114-119

Karger

Access to resources Recommend Favorite